LifeMD Inc
For the period ended Dec 31, 2024. Filed Mar 11, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 11, 2025
LFMD$1.74-16.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders’ (Deficit) Equity
| LifeMD, Inc. | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred Stock · Common Stock · Additional Paid-in · Accumulated · Treasury · Non-controlling | ||||||||||
| Shares | Amount | Shares | Amount | Capital | Deficit | Stock | Total | Interest | Total | |
| Balance, December 31, 2022 | 1,400,000 | $140 | 31,552,775 | $315,528 | $179,015,250 | $(190,562,994) | $(163,701) | $(11,395,777) | $(475,548) | $(11,871,325) |
| Stock compensation expense | - | - | 978,500 | 9,785 | 12,479,558 | - | - | 12,489,343 | - | 12,489,343 |
| Cashless exercise of stock options | - | - | 74,372 | 744 | (744) | - | - | - | - | - |
| Cashless exercise of warrants | - | - | 79,330 | 793 | (793) | - | - | - | - | - |
| Exercise of stock options | - | - | 37,500 | 375 | 94,125 | - | - | 94,500 | - | 94,500 |
| Stock issued for noncontingent consideration payments | - | - | 1,068,926 | 10,689 | 2,557,311 | - | - | 2,568,000 | - | 2,568,000 |
| Stock issued for legal settlement | - | - | 100,000 | 1,000 | 531,000 | - | - | 532,000 | - | 532,000 |
| Warrants issued with debt instrument | - | - | - | - | 873,100 | - | - | 873,100 | - | 873,100 |
| Sale of common stock under ATM, net | - | - | 1,009,907 | 10,099 | 6,192,560 | - | - | 6,202,659 | - | 6,202,659 |
| Stock issued for debt conversion | - | - | 672,042 | 6,720 | 993,280 | - | - | 1,000,000 | - | 1,000,000 |
| Common stock issued to Medifast | - | - | 1,224,425 | 12,244 | 9,987,756 | - | - | 10,000,000 | - | 10,000,000 |
| Series B Preferred Stock conversion | - | - | 1,560,864 | 15,609 | 5,057,205 | - | - | 5,072,814 | - | 5,072,814 |
| Series A Preferred Stock dividends | - | - | - | - | - | (3,106,250) | - | (3,106,250) | - | (3,106,250) |
| Distributions to non-controlling interest | - | - | - | - | - | - | - | - | (144,000) | (144,000) |
| Adjustment of membership interest in WorkSimpli | - | - | - | - | (229,025) | - | - | (229,025) | (76,600) | (305,625) |
| Net (loss) income | - | - | - | - | - | (20,595,992) | - | (20,595,992) | 2,756,935 | (17,839,057) |
| Balance, December 31, 2023 | 1,400,000 | $140 | 38,358,641 | $383,586 | $217,550,583 | $(214,265,236) | $(163,701) | $3,505,372 | $2,060,787 | $5,566,159 |
| Stock compensation expense | - | - | 1,609,960 | 16,100 | 12,218,697 | - | - | 12,234,797 | - | 12,234,797 |
| Stock issued for noncontingent consideration payment | - | - | 95,821 | 958 | 641,042 | - | - | 642,000 | - | 642,000 |
| Exercise of stock options | - | - | 86,250 | 863 | 119,449 | - | - | 120,312 | - | 120,312 |
| Cashless exercise of warrants | - | - | 1,630,458 | 16,305 | (16,305) | - | - | - | - | - |
| Cashless exercise of stock options | - | - | 512,777 | 5,127 | (5,127) | - | - | - | - | - |
| Series A Preferred Stock dividends | - | - | - | - | - | (3,106,250) | - | (3,106,250) | - | (3,106,250) |
| Distributions to non-controlling interest | - | - | - | - | - | - | - | - | (773,888) | (773,888) |
| Net (loss) income | - | - | - | - | - | (18,881,732) | - | (18,881,732) | 153,234 | (18,728,498) |
| Balance, December 31, 2024 | 1,400,000 | $140 | 42,293,907 | $422,939 | $230,508,339 | $(236,253,218) | $(163,701) | $(5,485,501) | $1,440,133 | $(4,045,368) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.